Genprex (GNPX) vs Lakewood-Amedex Biotherapeutics (LABT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Genprex is the larger company by market cap ($2.3 million vs $1.9 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GNPX | LABT |
|---|---|---|
| Share price | $2.75 | $0.792 |
| Market cap | $2.25M | $1.88M |
| 1-day change | +4.96% | -6.80% |
| EPS (TTM) | $-9.35 | $-8.83 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1,210.00 | $98.20 |
| 52-week low | $2.53 | $0.76 |
| Distance from 52-week high | -99.77% | -99.19% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +1415.15% |
| Average volume | 247.06K | 2.50M |
| Shares outstanding | 819.71K | 2.37M |
| Employees | 13 | 5 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Genprex
GNPX stock →Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes.
Healthcare · Biotechnology · 13 employees
About Lakewood-Amedex Biotherapeutics
LABT stock →Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States.
Healthcare · Biotechnology · 5 employees
GNPX vs LABT FAQ
Which is bigger, Genprex or Lakewood-Amedex Biotherapeutics?
Genprex (GNPX) is larger, with a market capitalization of $2.25M compared with $1.88M for Lakewood-Amedex Biotherapeutics (LABT).
Are Genprex and Lakewood-Amedex Biotherapeutics in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.